The QCMD (Quality Control for Molecular Diagnostics, www.qcmd.org) is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation. QCMD provides a wide-ranging quality assessment service primarily focused on molecular infectious diseases to over 2000 participants in over 100 countries. Their Human Papillomavirus (Preservcyt) EQA Programme assesses the proficiency of laboratories in the detection of different high risk HPV types within a PreservCyt® matrix.
In the latest November 2022 programme, laboratory using DiagCor’s GenoFlowTM HPV Array, together with DiagPuroTM Nucleic Acid Extraction System and DiagPuroTM Viral DNA/RNA Extraction Reagent has participated and attained fully proficient (100% proficient) status. In addition to the HPV subtypes covered by the proficiency programme, GenoFlowTM HPV Array Test Kit can genotype a total of 33 high- and low-risk HPV subtypes. DiagCor Life Science prioritizes high product quality and actively supports HPV genotyping services in laboratories worldwide.
Find the full details of the kit on the product page, or get in touch to learn more!
Acerca de DiagCor
Ubicados en Hong Kong, DiagCor se ha dedicado al desarrollo de pruebas moleculares (MDx) desde el 2006. Como líderes mundiales de la tecnología de hibridación rápida (flow-through hybridization), nuestra compañía ofrece una amplia gama de productos, soluciones y servicios relacionados con el análisis de ADN y ARN. Así mismo proveemos servicios de laboratorio MDx a médicos y profesionales en Asia Pacífica. DiagCor desarrolla y fabrica productos y soluciones MDx y a su vez ofrece consultoría en medicina translacional para proyectos MDx.
Contacto de prensa
DiagCor Life Science